Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis.

Marko LucijanicIvan KrecakDavor GalusicMartina SedinicHrvoje HolikVlatka PerisaMartina Moric PericIvan ZekanovicTajana Stoos-VeicVlatko PejsaRajko Kusec

Published in: Wiener klinische Wochenschrift (2021)

The PMF patients present with higher SUA levels, which are associated with features of more advanced disease and higher risks of arterial and venous thrombosis and death.

Keyphrases

uric acid
end stage renal disease
metabolic syndrome
ejection fraction
newly diagnosed
chronic kidney disease
human health
peritoneal dialysis
pulmonary embolism
patient reported outcomes
patient reported